Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment.

Among patients with multiple sclerosis (MS), fatigue is the most commonly reported symptom, and one of the most debilitating. Despite its high prevalence and significant impact, fatigue is still poorly understood and often under-emphasized because of its complexity and subjective nature. In recent years, an abundance of literature from specialists in sleep medicine, neurology, psychiatry, psychology, physical medicine and rehabilitation, and radiology have shed light on the potential causes, impact, and treatment of MS-related fatigue. Though such a diversity of contributions clearly has advantages, few recent articles have attempted to synthesize this literature, and existing overviews have focused primarily on potential causes of fatigue rather than clinical evaluation or treatment. The aims of this review are to examine, in particular for sleep specialists, the most commonly proposed primary and secondary mechanisms of fatigue in MS, tools for assessment of fatigue in this setting, and available treatment approaches to a most common and challenging problem.

[1]  R. Brown,et al.  The assessment of fatigue: a practical guide for clinicians and researchers. , 2004, Journal of psychosomatic research.

[2]  E. Willoughby,et al.  A Randomized Controlled Trial of Cognitive Behavior Therapy for Multiple Sclerosis Fatigue , 2008, Psychosomatic medicine.

[3]  R. Chervin,et al.  Sleepiness, fatigue, tiredness, and lack of energy in obstructive sleep apnea. , 2000, Chest.

[4]  D. Arnold,et al.  The relationship between diffuse axonal damage and fatigue in multiple sclerosis. , 2004, Archives of neurology.

[5]  S. Wessely,et al.  Development of a fatigue scale. , 1993, Journal of psychosomatic research.

[6]  Remmers Je,et al.  Multiple sclerosis with medullary plaques and fatal sleep apnea (Ondine's curse). , 1996 .

[7]  A. Cross,et al.  Fatigue therapy in multiple sclerosis , 1995, Neurology.

[8]  R. P. Fabio,et al.  Extended outpatient rehabilitation: its influence on symptom frequency, fatigue, and functional status for persons with progressive multiple sclerosis. , 1998, Archives of physical medicine and rehabilitation.

[9]  M. Holick.  Vitamin D deficiency. , 2007, The New England journal of medicine.

[10]  D. Wade,et al.  A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the “Cari Loder regime”) in the treatment of multiple sclerosis , 2002, Journal of neurology, neurosurgery, and psychiatry.

[11]  X. Montalban,et al.  Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS? , 2005, Multiple sclerosis.

[12]  Hank C. Lee,et al.  A randomized controlled study of the acute and chronic effects of cooling therapy for MS , 2003, Neurology.

[13]  J. Montplaisir,et al.  Increased frequency of restless legs syndrome in a French-Canadian population with multiple sclerosis , 2005, Neurology.

[14]  J. Kesselring,et al.  Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis , 2002, Multiple sclerosis.

[15]  T. Price,et al.  Characterization of major depression symptoms in multiple sclerosis patients. , 1996, The Journal of neuropsychiatry and clinical neurosciences.

[16]  D. Arnold,et al.  Mental fatigue alters the pattern and increases the volume of cerebral activation required for a motor task in multiple sclerosis patients with fatigue , 2008, European journal of neurology.

[17]  B. Weinshenker,et al.  A double‐blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis , 1992, Neurology.

[18]  G. Comi,et al.  Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damage , 2008, Multiple sclerosis.

[19]  Daniel J Buysse,et al.  The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research , 1989, Psychiatry Research.

[20]  Lauren B. Krupp,et al.  Fatigue in multiple sclerosis. , 1988, Archives of neurology.

[21]  R. Hirsch,et al.  Lymphocytes from multiple sclerosis patients produce elevated levels of gamma interferonin vitro , 1985, Journal of Clinical Immunology.

[22]  X. Montalban,et al.  Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone , 2006, Multiple sclerosis.

[23]  Rohit Bakshi,et al.  Quality of life in patients with multiple sclerosis The impact of fatigue and depression , 2002, Journal of the Neurological Sciences.

[24]  W. Ammann,et al.  Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue , 1997, Neurology.

[25]  M. Littner,et al.  Practice parameters for the evaluation of chronic insomnia. An American Academy of Sleep Medicine report. Standards of Practice Committee of the American Academy of Sleep Medicine. , 2000, Sleep.

[26]  M. Filippi,et al.  High prevalence of restless legs syndrome in multiple sclerosis , 2007, European journal of neurology.

[27]  F. Weber,et al.  Cytokine mRNA expression in patients with multiple sclerosis and fatigue , 2004, Multiple sclerosis.

[28]  C Trenkwalder,et al.  Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters , 2002, Multiple sclerosis.

[29]  R Bakshi,et al.  Fatigue in multiple sclerosis and its relationship to depression and neurologic disability , 2000, Multiple sclerosis.

[30]  W. Poewe,et al.  Auditory startle reaction is disinhibited in idiopathic restless legs syndrome. , 2007, Sleep.

[31]  A. Cleare,et al.  The neuroendocrinology of chronic fatigue syndrome. , 2003, Endocrine reviews.

[32]  G. Karst,et al.  Effects of an Aquatics Exercise Program on Quality of Life Measures for Individuals with Progressive Multiple Sclerosis , 2004 .

[33]  S. Saip,et al.  Fatigue and sleep disturbance in multiple sclerosis , 2006, European journal of neurology.

[34]  A. Cross,et al.  The relationship of sleep disturbances and fatigue in multiple sclerosis. , 2004, Archives of neurology.

[35]  G. Gigli,et al.  Prevalence of 'poor sleep' among patients with multiple sclerosis: an independent predictor of mental and physical status. , 2009, Sleep medicine.

[36]  T. Young,et al.  Epidemiology of restless legs symptoms in adults. , 2000, Archives of internal medicine.

[37]  R. Cohen,et al.  Amantadine treatment of fatigue associated with multiple sclerosis. , 1989, Archives of neurology.

[38]  F. Holsboer,et al.  Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis. , 2005, Archives of neurology.

[39]  H. Nagaraja,et al.  Efficacy and safety of modafinil (Provigil®) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study , 2002, Journal of neurology, neurosurgery, and psychiatry.

[40]  R. Boland.  Role of vitamin D in skeletal muscle function. , 1986, Endocrine reviews.

[41]  T. Vollmer,et al.  Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey , 2008, Health and quality of life outcomes.

[42]  C. Chen,et al.  Adrenal Androgens and the Immune System , 2004, Seminars in reproductive medicine.

[43]  H. Glerup,et al.  Hypovitaminosis D Myopathy Without Biochemical Signs of Osteomalacic Bone Involvement , 2000, Calcified Tissue International.

[44]  E. Celius,et al.  A prospective study of patterns of fatigue in multiple sclerosis , 2007, European journal of neurology.

[45]  U. Keil,et al.  Prevalence and risk factors of RLS in an elderly population , 2000, Neurology.

[46]  R. Chervin,et al.  Fatigue, tiredness, and lack of energy improve with treatment for OSA. , 2009, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[47]  M. Maes,et al.  Decreased dehydroepiandrosterone sulfate but normal insulin-like growth factor in chronic fatigue syndrome (CFS): relevance for the inflammatory response in CFS. , 2005, Neuro endocrinology letters.

[48]  D. Aarsland,et al.  Neuropsychiatric symptoms in patients with multiple sclerosis , 2005, Acta psychiatrica Scandinavica.

[49]  L. Krupp,et al.  Fatigue is intrinsic to multiple sclerosis (MS) and is the most commonly reported symptom of the disease. , 2006, Multiple sclerosis.

[50]  F Barkhof,et al.  Fatigue in multiple sclerosis: Interrelations between fatigue complaints, cerebral MRI abnormalities and neurological disability , 1998, Journal of the Neurological Sciences.

[51]  M. Ulivelli,et al.  Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study. , 2008, Sleep.

[52]  S. Gold,et al.  Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[53]  M. Subirá,et al.  Modalities of fatigue in multiple sclerosis: correlation with clinical and biological factors , 2000, Multiple sclerosis.

[54]  J. Kesselring,et al.  Fatigue in multiple sclerosis is not due to sleep apnoea , 1997, European journal of neurology.

[55]  G. Lavigne,et al.  Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. , 1994, Sleep.

[56]  J. Fisk,et al.  The Impact of Fatigue on Patients with Multiple Sclerosis , 1994, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[57]  P. Arnett,et al.  Factors related to employment status changes in individuals with multiple sclerosis , 2005, Multiple sclerosis.

[58]  M. Sharief,et al.  Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis , 1991 .

[59]  S. Hochman,et al.  Restless legs syndrome , 2006, Neurology.

[60]  S. Lynch,et al.  Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern , 2000, Multiple sclerosis.

[61]  M. Clanet,et al.  Modafinil for fatigue in MS , 2005, Neurology.

[62]  J F Reed,et al.  Sensory symptoms of multiple sclerosis: a hidden reservoir of morbidity , 1999, Multiple sclerosis.

[63]  L. Krupp,et al.  Longitudinal correlates of fatigue in multiple sclerosis , 2009, Multiple sclerosis.

[64]  M. Johns,et al.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale. , 1991, Sleep.

[65]  G. Ruiz-Irastorza,et al.  Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. , 2008, Rheumatology.

[66]  À. Rovira,et al.  The basal ganglia: a substrate for fatigue in multiple sclerosis , 2007, Neuroradiology.

[67]  E. Bixler,et al.  Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. , 2004, The Journal of clinical endocrinology and metabolism.

[68]  J. Herbert,et al.  High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis , 1994, Neurology.

[69]  D. Miller,et al.  Sleep problems in multiple sclerosis. , 1994, European neurology.